Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.7.1.4 (
nitrite reductase
)
1,847
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Staphylococcus aureus
nitric oxide synthase (saNOS) is a major contributor to virulence, stress resistance, and physiology, yet the specific mechanism(s) by which saNOS intersects with other known regulatory circuits is largely unknown. The SrrAB two-component system, which modulates gene expression in response to the reduced state of respiratory menaquinones, is a positive regulator of
nos
expression. Several SrrAB-regulated genes were also previously shown to be induced in an aerobically respiring
nos
mutant, suggesting a potential interplay between saNOS and SrrAB. Therefore, a combination of genetic, molecular, and physiological approaches was employed to characterize a
nos srrAB
mutant, which had significant reductions in the maximum specific growth rate and oxygen consumption when cultured under conditions promoting aerobic respiration. The
nos srrAB
mutant secreted elevated lactate levels, correlating with the increased transcription of lactate dehydrogenases. Expression of nitrate and
nitrite reductase
genes was also significantly enhanced in the
nos srrAB
double mutant, and its aerobic growth defect could be partially rescued with supplementation with nitrate, nitrite, or ammonia. Furthermore, elevated
ornithine
and citrulline levels and highly upregulated expression of arginine deiminase genes were observed in the double mutant. These data suggest that a dual deficiency in saNOS and SrrAB limits
S. aureus
to fermentative metabolism, with a reliance on nitrate assimilation and the urea cycle to help fuel energy production. The
nos
,
srrAB
, and
nos srrAB
mutants showed comparable defects in endothelial intracellular survival, whereas the
srrAB
and
nos srrAB
mutants were highly attenuated during murine sepsis, suggesting that SrrAB-mediated metabolic versatility is dominant
in vivo
.
...
PMID:Interplay of Nitric Oxide Synthase (NOS) and SrrAB in Modulation of
Staphylococcus aureus
Metabolism and Virulence. 3042 Apr 50